PYPD
PolyPidยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PYPD Profile
Polypid Ltd.
A biopharmaceutical company developing and commercializing extended-release, locally administered therapies
18 Hasivim Street, Petach Tikva 4959376, Israel
--
PolyPid Ltd., incorporated under the laws of Israel, commenced operations on February 28, 2008. The Company is a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, topically administered and sustained-release therapies using proprietary PLEX technology. The company's product candidates are designed to address diseases with high unmet medical need by pairing PLEX technology with FDA-approved drugs or innovative drug candidates to achieve new therapeutic effects.
